This is just a tiny glimpse of the data available to CivicScience clients. Discover more data. CivicScience has data on over ...

When every second counts, Baltimore non profit, We Responders Inc., trains people on how to respond in emergency situations.

In this episode of Targeted Talks, Aditya Bardia, MD, MPH, FASCO, discusses the recent FDA approval of datopotamab deruxtecan ...

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion.

Ultragenyx Pharmaceutical RARE reported new findings from an ongoing, pivotal study of its investigational candidate, UX111 (ABO-102) AAV gene therapy, for Sanfilippo syndrome type A (MPS IIIA). Per ...

Women living in rural Appalachia who are at high-risk of HIV had effective interventions delivered through Facebook.

On October 14, 2024, the FDA approved a 320-mg single dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms are now commercially available in the US.

Kura and Kyowa used the announcement to confirm that they are on track to file a new drug approval application with the FDA ...

Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get ...

And with a growing number of companies in the GLP-1 space, investors may be losing interest in the stock. Could Viking's ...